Grants and Contributions:
Title:
UK BioM-10139996-PHAGOPRODUCTION-GMP compliant large scale biomanufacturing of bacteriophages to tackle AMR care continuum from diagnosis to therapy
Agreement Number:
1029004
Agreement Value:
$499,999.00
Agreement Date:
Apr 1, 2025 - Mar 30, 2027
Description:
This Canada-UK collaborative project aims to establish large-scale, GMP (Good Manufacturing Practices)-compliant manufacturing of bacteriophages to combat antimicrobial-resistant infections. Using an innovative bioreactor, the team will scale up production for several phage candidates targeting WHO-priority pathogens. The project integrates innovative technologies for phage characterization and rapid diagnostic testing.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Gatineau, Quebec, CA J9J 3K3
Reference Number:
172-2025-2026-Q1-1029004
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
789858214
Recipient Type:
For-profit organization
Recipient's Legal Name:
Qeen Biotechnologies Inc.
Federal Riding Name:
Pontiac
Federal Riding Number:
24057
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710